LiverAlertMe is a medical tracking app for NAFLD/MASLD management, offering symptom logging, meal suggestions, and FIB-4 risk assessment on iOS.
The App DNA
What makes this app unique?
The app removes the friction of manual liver-health monitoring by providing a specialist-designed, structured workflow that replaces generic health-tracking spreadsheets.
For Individuals diagnosed with or at risk for NAFLD/MASLD and healthcare providers monitoring patients with metabolic liver conditions.
What does it look like?
Key features
Content and tracking tools developed by a liver specialist with clinical experience in MASLD and NAFLD management.
Traffic-light meal recommendations generated via text or voice input.
Medical tool for assessing liver fibrosis risk based on validated clinical metrics.
How much does it cost?
Freemium model anchored at $29.99/year, gating advanced analytics and personalized meal plans behind a 7-day free trial.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app maintains a maintenance-level velocity, with only one release identified in the recent window. The latest release focuses exclusively on minor bug fixes and data display adjustments. Development appears stable but limited to technical maintenance rather than new feature expansion. The current cadence of approximately one release every five to six weeks suggests a focus on long-term stability over active feature development.
Who built it?
Worthy Works
7 apps tracked · Medical
User Sentiment
What do users think recently?
Review voice lately leans upset.
How are ratings & reviews evolving?
What users say, by theme
- Users report the app fails to recognize active annual subscriptions after purchase, blocking access to features
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for LiverAlertMe: Fatty Liver Care
How's the Medical market?
LiverAlertMe occupies a niche medical-tracking segment, currently maintaining a 4.1-star rating across 17 total ratings. The lack of recent major feature updates suggests a maintenance-focused posture that leaves the app vulnerable to competitors with more frequent release cycles.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for LiverAlertMe: Fatty Liver Care
Where is it heading?
The metabolic health market is consolidating around platforms that offer seamless data integration and high-frequency updates. LiverAlertMe's current maintenance-only posture, combined with critical subscription-access failures, suggests a declining trend that will likely accelerate churn unless the core validation logic is rebuilt.
- Subscription validation failures in the latest release block premium access, which directly erodes trust and drives immediate churn among paying users.
- The 38-day maintenance-only update cadence indicates a lack of active feature investment, which leaves the app vulnerable to better-resourced digital health competitors.
The SWOT
- Specialist-designed tracking tools build clinical trust
- FIB-4 calculator provides high-utility medical assessment
- Integration with wearable health data for automation
- Expansion of meal-suggestion database for diverse diets
Next best moves
Rebuild subscription validation logic because users report active annual subscriptions are not recognized → restore premium access
+ 1 more prioritized moveThe counter-intuitive read
The app's specialist-design is a liability if the…
Read the full takeBottom line
Subscription validation failures currently break the monetization loop, preventing paying users from accessing the premium features they purchased. Resolving this access blocker is the primary requirement to stabilize retention and prevent churn among the existing user base.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated